236 related articles for article (PubMed ID: 3518930)
21. [Immune complexes in neoplastic diseases and autoimmune processes].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG; Vygovskaia IaI; Zakharchuk LS
Vopr Onkol; 1983; 29(8):3-7. PubMed ID: 6613066
[TBL] [Abstract][Full Text] [Related]
22. [Immune complexes as markers in breast cancer and melanoma].
Cappellari A; Corradi G
Boll Ist Sieroter Milan; 1987; 66(4):303-7. PubMed ID: 3442620
[TBL] [Abstract][Full Text] [Related]
23. Detection of bovine serum albumin in the circulating IgA immune complexes of patients with IgA nephropathy.
Yap HK; Sakai RS; Woo KT; Lim CH; Jordan SC
Clin Immunol Immunopathol; 1987 Jun; 43(3):395-402. PubMed ID: 3581518
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in cancer patients.
Jaramillo S; Shafir M; Bekesi G
Immunol Invest; 1987 Aug; 16(5):383-98. PubMed ID: 3692551
[TBL] [Abstract][Full Text] [Related]
26. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
28. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
Wong JH; Aguero B; Gupta RK; Morton DL
Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
[TBL] [Abstract][Full Text] [Related]
29. Immune complexes and carcinoembryonic antigen levels in metastatic choroidal tumors.
Char DH; Christensen M
Am J Ophthalmol; 1980 May; 89(5):628-31. PubMed ID: 7377259
[TBL] [Abstract][Full Text] [Related]
30. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera.
Krapf F; Renger D; Schedel I; Leiendecker K; Leyssens H; Deicher H
J Immunol Methods; 1982 Oct; 54(1):107-17. PubMed ID: 7142715
[No Abstract] [Full Text] [Related]
31. Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.
Kelley MC; Jones RC; Gupta RK; Yee R; Stern S; Wanek L; Morton DL
Cancer; 1998 Oct; 83(7):1355-61. PubMed ID: 9762936
[TBL] [Abstract][Full Text] [Related]
32. The fluctuation of circulating immune complexes level in patients with malignancy.
Vodvárka P; Vodvárka T; Foukalová J
Neoplasma; 1984; 31(4):485-9. PubMed ID: 6472521
[TBL] [Abstract][Full Text] [Related]
33. Formation and glomerular deposition of immune complexes in mice administered bovine serum albumin: Evaluation of dose, frequency, and biomarkers.
Boysen L; Viuff BM; Landsy LH; Price SA; Raymond JT; Lykkesfeldt J; Lauritzen B
J Immunotoxicol; 2019 Dec; 16(1):191-200. PubMed ID: 31684787
[TBL] [Abstract][Full Text] [Related]
34. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.
Vlock DR; Kirkwood JM
J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634
[TBL] [Abstract][Full Text] [Related]
35. C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.
Manzo C; Longo C; Bianchin A
Tumori; 1982 Feb; 68(1):47-52. PubMed ID: 7041380
[TBL] [Abstract][Full Text] [Related]
36. Relationship between circulating immune complexes and urinary antigens in human malignancy.
Huth JF; Gupta RK; Morton DL
Cancer; 1982 Mar; 49(6):1150-7. PubMed ID: 7037157
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes in patients with breast cancer.
Hoffken K; Meredith ID; Robins RA; Baldwin RW; Davies CJ; Blamey RW
Br Med J; 1977 Jul; 2(6081):218-20. PubMed ID: 884444
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.
Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL
Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173
[TBL] [Abstract][Full Text] [Related]
39. Investigation of circulating immune complexes in patients with breast cancer.
Horváth M; Fekete B; Rahóty P
Oncology; 1982; 39(1):20-2. PubMed ID: 7058043
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility and monitoring of breast cancer by circulating immune complexes.
Dass TK; Aziz M; Rattan A; Tyagi SP
Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
